GENMAB A/S Annual Research And Development Expense in DKK from 2017 to 2024

Taxonomy & unit
ifrs-full: DKK
Summary
Genmab A/S annual/quarterly Research And Development Expense history and growth rate from 2017 to 2024.
  • Genmab A/S Research And Development Expense for the quarter ending June 30, 2024 was 2.5B DKK, a 35% increase year-over-year.
  • Genmab A/S annual Research And Development Expense for 2024 was 9.75B DKK, a 27.8% increase from 2023.
  • Genmab A/S annual Research And Development Expense for 2023 was 7.63B DKK, a 37.2% increase from 2022.
  • Genmab A/S annual Research And Development Expense for 2022 was 5.56B DKK, a 33% increase from 2021.
Research And Development Expense, Annual (DKK)
Research And Development Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2024 9.75B +2.12B +27.8% Jan 1, 2024 Dec 31, 2024 6-K 2025-02-12
2023 7.63B +2.07B +37.2% Jan 1, 2023 Dec 31, 2023 6-K 2025-02-12
2022 5.56B +1.38B +33% Jan 1, 2022 Dec 31, 2022 6-K 2025-02-12
2021 4.18B +1.04B +33.3% Jan 1, 2021 Dec 31, 2021 6-K 2024-02-14
2020 3.14B +751M +31.5% Jan 1, 2020 Dec 31, 2020 6-K 2023-02-22
2019 2.39B +955M +66.7% Jan 1, 2019 Dec 31, 2019 6-K 2022-02-16
2018 1.43B +557M +63.7% Jan 1, 2018 Dec 31, 2018 6-K 2021-02-23
2017 874M Jan 1, 2017 Dec 31, 2017 20-F 2020-03-30
* An asterisk sign (*) next to the value indicates that the value is likely invalid.